It was postulated that VEGF could be a neurotrophic factor and monthly frequent injection might cause retina and retinal pigment epithelium damage, causing geographic atrophy and in the long run deteriorate patients' vision.29 However, new evidence has shown that prolonged VEGF blockage is not neurotoxic and monthly injection of anti‐VEGF is necessary to maintain a patient's long‐term visual gain.11, 30, 31. Here, VEGFA is linked to atrophic macular degeneration.